Literature DB >> 21882803

Mechanisms controlling the cellular accumulation of copper bis(thiosemicarbazonato) complexes.

Katherine Ann Price1, Peter J Crouch, Irene Volitakis, Brett M Paterson, SinChun Lim, Paul S Donnelly, Anthony R White.   

Abstract

Copper (Cu) bis(thiosemicarbazonato) metal complexes [Cu(II)(btsc)s] have unique tumor-imaging and treatment properties and more recently have revealed potent neuroprotective actions in animal and cell models of neurodegeneration. However, despite the continued development of Cu(II)(btsc)s as potential therapeutics or diagnostic agents, little is known of the mechanisms involved in cell uptake, subcellular trafficking, and efflux of this family of compounds. Because of their high lipophilicity, it has been assumed that cellular accumulation is through passive diffusion, although this has not been analyzed in detail. The role of efflux pathways in cell homeostasis of the complexes is also largely unknown. In the present study, we investigated the cellular accumulation of the Cu(II)(btsc) complexes Cu(II)(gtsm) and Cu(II)(atsm) in human neuronal (M17) and glial (U87MG) cell lines under a range of conditions. Collectively, the data strongly suggested that Cu(II)(gtsm) and Cu(II)(atsm) may be taken into these cells by combined passive and facilitated (protein-carrier-mediated) mechanisms. This was supported by strong temperature-dependent changes to the uptake of the complexes and the influence of the cell surface protein on Cu accumulation. We found no evidence to support a role for copper-transporter 1 in accumulation of the compounds. Importantly, our findings also demonstrated that Cu from both Cu(II)(gtsm) and Cu(II)(atsm) was rapidly effluxed from the cells through active mechanisms. Whether this was in the form of released ionic Cu or as an intact metal complex is not known. However, this finding highlighted the difficulty of trying to determine the uptake mechanism of metal complexes when efflux is occurring concomitantly. These findings are the first detailed exploration of the cellular accumulation mechanisms of Cu(II)(btsc)s. The study delineates strategies to investigate the uptake and efflux mechanisms of metal complexes in cells, while highlighting specific difficulties and challenges that need to be considered before drawing definitive conclusions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21882803     DOI: 10.1021/ic201334q

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  19 in total

1.  Copper-64-diacetyl-bis(N(4)-methylthiosemicarbazone) pharmacokinetics in FaDu xenograft tumors and correlation with microscopic markers of hypoxia.

Authors:  Keisha C McCall; John L Humm; Rachel Bartlett; Megan Reese; Sean Carlin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-23       Impact factor: 7.038

2.  Ratiometric two-photon microscopy reveals attomolar copper buffering in normal and Menkes mutant cells.

Authors:  M Thomas Morgan; Daisy Bourassa; Shefali Harankhedkar; Adam M McCallum; Stephanie A Zlatic; Jenifer S Calvo; Gabriele Meloni; Victor Faundez; Christoph J Fahrni
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-03       Impact factor: 11.205

3.  Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells.

Authors:  Kenichi Shimada; Eduard Reznik; Michael E Stokes; Lakshmi Krishnamoorthy; Pieter H Bos; Yuyu Song; Christine E Quartararo; Nen C Pagano; Darren R Carpizo; Ana C deCarvalho; Donald C Lo; Brent R Stockwell
Journal:  Cell Chem Biol       Date:  2018-03-22       Impact factor: 8.116

4.  Bis(thiosemicarbazone) copper complexes: mechanism of intracellular accumulation.

Authors:  Catherine Lambert; Heloisa Beraldo; Nicole Lievre; Arlette Garnier-Suillerot; Pierre Dorlet; Milena Salerno
Journal:  J Biol Inorg Chem       Date:  2012-10-27       Impact factor: 3.358

5.  Copper(II)-Bis(Thiosemicarbazonato) Complexes as Antibacterial Agents: Insights into Their Mode of Action and Potential as Therapeutics.

Authors:  Karrera Y Djoko; Maira M Goytia; Paul S Donnelly; Mark A Schembri; William M Shafer; Alastair G McEwan
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

6.  Activation of artemisinin and heme degradation in Leishmania tarentolae promastigotes: A possible link.

Authors:  Gerald Geroldinger; Matthias Tonner; Judith Quirgst; Martin Walter; Sritama De Sarkar; Laura Machín; Lianet Monzote; Klaus Stolze; J Catharina Duvigneau; Katrin Staniek; Mitali Chatterjee; Lars Gille
Journal:  Biochem Pharmacol       Date:  2019-11-29       Impact factor: 5.858

Review 7.  A nuclear chocolate box: the periodic table of nuclear medicine.

Authors:  Philip J Blower
Journal:  Dalton Trans       Date:  2015-03-21       Impact factor: 4.390

8.  PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer Disease.

Authors:  Julia Baguña Torres; Erica M Andreozzi; Joel T Dunn; Muhammad Siddique; Istvan Szanda; David R Howlett; Kavitha Sunassee; Philip J Blower
Journal:  J Nucl Med       Date:  2015-10-08       Impact factor: 10.057

9.  Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosis.

Authors:  Katja M Kanninen; Alexandra Grubman; Aphrodite Caragounis; Clare Duncan; Sarah J Parker; Grace E Lidgerwood; Irene Volitakis; George Ganio; Peter J Crouch; Anthony R White
Journal:  Biol Open       Date:  2013-05-20       Impact factor: 2.422

10.  Alteration of Cellular Reduction Potential Will Change 64Cu-ATSM Signal With or Without Hypoxia.

Authors:  John M Floberg; Lingjue Wang; Nilantha Bandara; Ramachandran Rashmi; Cedric Mpoy; Joel R Garbow; Buck E Rogers; Gary J Patti; Julie K Schwarz
Journal:  J Nucl Med       Date:  2019-10-04       Impact factor: 11.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.